196 related articles for article (PubMed ID: 31365766)
1. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.
Watanabe T; Martinu T; Chruscinski A; Boonstra K; Joe B; Horie M; Guan Z; Bei KF; Hwang DM; Liu M; Keshavjee S; Juvet SC
Am J Transplant; 2019 Dec; 19(12):3377-3389. PubMed ID: 31365766
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
3. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
[TBL] [Abstract][Full Text] [Related]
4. Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4
Guo Y; Wang Q; Li D; Onyema OO; Mei Z; Manafi A; Banerjee A; Mahgoub B; Stoler MH; Barker TH; Wilkes DS; Gelman AE; Kreisel D; Krupnick AS
Am J Transplant; 2019 Oct; 19(10):2705-2718. PubMed ID: 31278849
[TBL] [Abstract][Full Text] [Related]
5. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
[TBL] [Abstract][Full Text] [Related]
6. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
[TBL] [Abstract][Full Text] [Related]
7. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
[TBL] [Abstract][Full Text] [Related]
8. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
[TBL] [Abstract][Full Text] [Related]
9. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation.
Matsuda Y; Wang X; Oishi H; Guan Z; Saito M; Liu M; Keshavjee S; Chow CW
Am J Transplant; 2016 Jan; 16(1):342-52. PubMed ID: 26308240
[TBL] [Abstract][Full Text] [Related]
10. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
[TBL] [Abstract][Full Text] [Related]
11. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
[TBL] [Abstract][Full Text] [Related]
12. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
[TBL] [Abstract][Full Text] [Related]
13. The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
Aoki Y; Walker NM; Misumi K; Mimura T; Vittal R; McLinden AP; Fitzgerald L; Combs MP; Lyu D; Osterholzer JJ; Pinsky DJ; Lama VN
J Heart Lung Transplant; 2023 Mar; 42(3):317-326. PubMed ID: 36522238
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation.
Matsumura Y; Marchevsky A; Zuo XJ; Kass RM; Matloff JM; Jordan SC
Transplantation; 1995 Jun; 59(11):1509-17. PubMed ID: 7778165
[TBL] [Abstract][Full Text] [Related]
15. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
[TBL] [Abstract][Full Text] [Related]
16. Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.
Watanabe T; Lam C; Oliver J; Oishi H; Teskey G; Beber S; Boonstra K; Mauricio Umaña J; Buhari H; Joe B; Guan Z; Horie M; Keshavjee S; Martinu T; Juvet SC
Mucosal Immunol; 2023 Apr; 16(2):104-120. PubMed ID: 36842540
[TBL] [Abstract][Full Text] [Related]
17. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
18. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
19. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts.
Syrjälä SO; Tuuminen R; Nykänen AI; Raissadati A; Dashkevich A; Keränen MA; Arnaudova R; Krebs R; Leow CC; Saharinen P; Alitalo K; Lemström KB
Am J Transplant; 2014 May; 14(5):1096-108. PubMed ID: 24708486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
